2000
DOI: 10.1016/s0968-0896(00)00177-2
|View full text |Cite
|
Sign up to set email alerts
|

Design and synthesis of potential inhibitors of the ergosterol biosynthesis as antifungal agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
12
0

Year Published

2008
2008
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(13 citation statements)
references
References 26 publications
1
12
0
Order By: Relevance
“…Indeed, this has already been confirmed with some transition-state analogues, and dual inhibitors of CYP51 and ERG6 have also been reported [60].…”
Section: Erg6 (Sterol C-24 Methyltransferases)supporting
confidence: 59%
See 1 more Smart Citation
“…Indeed, this has already been confirmed with some transition-state analogues, and dual inhibitors of CYP51 and ERG6 have also been reported [60].…”
Section: Erg6 (Sterol C-24 Methyltransferases)supporting
confidence: 59%
“…Therefore, several transition-state analogue inhibitors of ERG6 with nM K i values have already been designed [58]. As fungal cells treated with antifungal azoles often respond with mutations, and alternated pathway of ergosterol synthesis [58], dual inhibitors might be more efficient than inhibitors of the individual enzymes [60].…”
Section: Potential Application Of Ergosterol Biosynthetic Enzymesmentioning
confidence: 99%
“…Though some promising compounds with in vitro activities against Erg6p have already been synthesised (e.g. [ 53 54 ]), much more work is still needed to develop new and efficient antifungal drugs targeting ergosterol biosynthesis, mainly due to a rapidly increasing number of clinical isolates resistant to classical ergosterol-pathway-targeted antifungal drugs [ 55 56 ].…”
Section: Resultsmentioning
confidence: 99%
“…We found several interesting patterns after transfer to nitrogen-deficient (Y-D) medium that may be associated with stationary phase such as histone H1, important for DNA packaging [93]. Erg6 is a protein in the ergosterol biosynthetic pathway, used as a lipid droplet marker, and a target of antifungals [94, 95]. It has also been identified by proteomics in Y. lipolytica lipid droplets [56], and here shows changing lipid droplet size and number.…”
Section: Resultsmentioning
confidence: 99%